Laser and Light-Based Treatments for Pigmented Lesions

Total Page:16

File Type:pdf, Size:1020Kb

Laser and Light-Based Treatments for Pigmented Lesions AESTHETIC FOCUS Laser and light-based treatments for pigmented lesions BY PAOLO BONAN AND NICOLA BRUSCINO The authors detail the types of lasers and light-based devices that can be used in the treatment of epidermal and dermal pigmentations. kin colour differences have, for coherence and collimation and these vessel wall rupture and haemorrhaging. The centuries, been associated with characteristics differentiate laser light photothermal effect occurs when the energy the economic, political and social from non-laser light, such as intense pulsed of the irradiated photons is turned into heat Sstatus of a person; therefore, light (IPL). The absorption of photons by a due to the absorption of the photons by the appearance of a new pigmentation specific target is the scope of every laser the chromophores. The consequences may may imply a negative, emotional and treatment in order to cause a biological vary depending on the degree of heating psychological state. Non-white racial / effect; during this process all the energy reached in the target chromophore, the ethnic groups (African-Americans, Hispanics delivered by the photons is transmitted to duration of the target at that temperature, and Asians) often seek medical procedures the target structures, the chromophores. and lastly, the capacity to spread the heat to for the removal of pigmentation disorders Dermatological laser treatment changed the surrounding tissues. The photochemical due to the greater incidence of congenital radically in 1983 thanks to the introduction effect occurs when the absorbed photons and acquired pigmentary disorders among of the selective photothermolysis theory affect the cellular metabolism or influence these groups. by Anderson and Parrish, defining how to the signaling cascade. The consequences of These epidermal pigmentations are localise thermal injury to the target tissue, the photochemical effect include increased characterised by the melanin content in the thus minimising the damage to surrounding cell proliferation and migration, modulation epidermis or dermo epidermal junction: areas by choosing the adequate wavelength of growth factors, cytokines and other • Ephelides of light that the chromophore inside the mediators, increased tissue oxygenation, • Solar lentigo target tissue absorbs. and increased healing of wounds. • Lentigo simplex The absorption depends mainly on the Several laser and light devices are • Seborrheic keratoses matching of the wavelength of the photons available on the market for treating pigment • Dermatosis papulosa nigra with the absorption peak of a particular alterations: Q-switched neodymium- • Cafè-au-lait macules chromophore. The absorption by melanin, doped:yttrium aluminium garnet laser • Naevus spilus. ranging between 400 and 750nm, is (Nd:YAG) (532-1064nm), pulsed dye laser maximal in the ultraviolet area, decreasing (PDL) (595nm), Q-switched ruby laser Dermo epidermal lesions show the melanin throughout the visible region. (694nm), Q-switched alexandrite laser pigment at the epidermal and dermal The light absorption can cause three (755nm), picosecond alexandrite laser position: different types of biological effects in the (755nm), intense pulsed light (IPL) (590- • Post inflammatory hyperpigmentation skin: photomechanical, photothermal and 1200nm), as well as nonselective lasers, • Melasma photochemical. The photomechanical erbium:YAG laser (2940nm) and carbon • Becker’s naevus effect occurs when very short laser pulses, dioxide laser (CO2) (10600nm) through its • Junctional and compound melanocytic nanoseconds for the Q-switched laser fractional modality too [1-8]. nevi or picoseconds for the picosecond laser, • Congenital melanocytic nevi. produce very strong energies; in this Lasers and lights way the tissue undergoes rapid thermal Q-switched 532 nm Nd-YAG laser is the Dermal pigmented lesions are due to a expansion, and an optical breakdown with shortest wavelength laser employed for deeper melanin in the dermis: intense shockwaves. This photomechanical pigmented disorders removal (Figures 1-2). - Blue naevi effect is crucial for Q-switched lasers It is effective for superficial epidermal - Naevus of Ota and picosecond lasers that are able to pigmentations like solar lentigines and - Naevus of Ito. disrupt the melanin and ink content freckles. The treated lesion is characterised of hyperpigmentation and tattoos by the appearance of a typical pinpoint Lasers and light-based pigment (fragmentation of intracellular pigment bleeding and a haemorrhagic crust which removal: how they work into extracellular granules subsequently lasts five to six days before falling off. The majority of lasers used in medicine, phagocytised by macrophages), as well PDL uses a rhodamine dye dissolved in a and mainly in dermatology, generate light as being a determining factor for high- solvent and pumped by a flash lamp, emits in the ultraviolet (200-400nm), visible fluence, short-pulse, pulsed dye laser a 585-600nm wavelength yellow light, near (400-760nm), near-infrared (760-1400nm), treatment of vascular disorders. In fact, the haemoglobin absorption peak, and mid-infrared (1400-3000nm) and infrared (> photomechanical damage, which clinically therefore it is considered the most specific 3000nm) wavelengths. The typical features appears with purpura, is induced by short laser currently available for the treatment of laser light are its monochromaticity, pulses and causes intravascular cavitation, of superficial vascular lesions. It is also The PMFA Journal | DECEMBER/JANUARY 2018 | VOL 5 NO 2 | www.thepmfajournal.com AESTHETIC FOCUS commonly used for treating Poikiloderma like naevus of Ota and tattoos. Patients of Civatte and really superficial pigmented usually complain of more discomfort and a lesions like solar lentigines and ephelides, prolonged downtime. since its wavelengths are absorbed by IPL technology uses a xenon broadband melanin too (Figure 3). Despite its excellent flash lamp to generate non-coherent light efficacy and safety profile, the onset of in a spectrum between visible and near purpura would limit patients’ acceptance infrared (500-1300nm). To reach the desired as it may persist for 7 to 14 days after the chromophore, filters cut the light emission laser session due to micro vaporisation of according to the wavelengths required erythrocytes, vessel rupture and subsequent by the physician; consequently, this type haemorrhage; a pressure diascopy during of light source can excite more than one the PDL session removes the blood from the chromophore (haemoglobin, melanin, vessels by closing the vessel lumen, and the water). Its versatility entails a reduced removal of vascular component of the lesion selectivity. Handpieces have a large surface avoids the purpura after the PDL session for area, generally cooled, and application of treating lentigines. gel on the skin surface is required during the Q-switched ruby laser emits a 694nm procedure. For the treatment of pigmented beam of photons, being well absorbed by lesions IPL is not comparable with melanin and minimally by haemoglobin. Q-switched lasers since its pulse duration Figure 1: It is effective for the removal of superficial in the milliseconds range make it a second A) A 49-year-old female patient with solar lentigo on the left pigmentations, lentigines, ephelides and choice. IPL employment can give excellent cheek. results when the pigmentations are matched B) The disappearance of the most part of the solar lentigo pigmented actinic keratosis as well as after only one session of Q-switched 532nm Nd:YAG laser deeper pigmented lesions, melanocytic with vascular lesions (teleangiectasias, (SYNCHRO QS4, DEKA M.E.L.A., Calenzano, Italy). naevi, naevus of Ota, naevus of Ito. erythrosis, rosacea). Q-switched alexandrite emits at 755-nm, Er:YAG laser is a solid-state laser, belonging to the near-infrared category of characterised by the presence of erbium ions lasers. At this particular wavelength the inside ytrrium-aluminum-garnet or other main chromophore is melanin, hence it is crystals; it emits photons at wavelengths mainly used for hair removal and pigmented of 2940nm, which are mainly absorbed by lesions. Since alexandrite has a similar water in the superficial layers of the skin. wavelength with ruby laser, it shares the This laser system is generally used for same pigmented indications; the longer ablating the soft and hard tissues. Its main wavelength allows a deeper effect on drawback compared to other ablative lasers dermal melanin in fact its employment gives like CO2 is its inability to coagulate. Er:YAG excellent results for nevus of Ota. laser can be used for skin resurfacing with a Picosecond alexandrite laser is a safe fractional handpiece in a minimally ablative and effective modality for the removal manner too. of pigmentary disorders. Due to its great CO2 is a gas-state laser that emits success in tattoo removal, several physicians photons at wavelengths of 10600nm. It have started to employ it for treating offers a type of ‘no-contact surgery’. In different pigmentations with promising fact, this laser system enables precise, results. Its effectiveness results from a efficacious and targeted thermal action on greater pigment fragmentation induced the lesions treated while protecting the by deep shockwaves (photomechanical surrounding tissues, thus guaranteeing effect), while its safety originates from a optimal re-epithelisation. This makes it reduced and selective thermal damage suitable for surgical procedures since the
Recommended publications
  • Dermatology DDX Deck, 2Nd Edition 65
    63. Herpes simplex (cold sores, fever blisters) PREMALIGNANT AND MALIGNANT NON- 64. Varicella (chicken pox) MELANOMA SKIN TUMORS Dermatology DDX Deck, 2nd Edition 65. Herpes zoster (shingles) 126. Basal cell carcinoma 66. Hand, foot, and mouth disease 127. Actinic keratosis TOPICAL THERAPY 128. Squamous cell carcinoma 1. Basic principles of treatment FUNGAL INFECTIONS 129. Bowen disease 2. Topical corticosteroids 67. Candidiasis (moniliasis) 130. Leukoplakia 68. Candidal balanitis 131. Cutaneous T-cell lymphoma ECZEMA 69. Candidiasis (diaper dermatitis) 132. Paget disease of the breast 3. Acute eczematous inflammation 70. Candidiasis of large skin folds (candidal 133. Extramammary Paget disease 4. Rhus dermatitis (poison ivy, poison oak, intertrigo) 134. Cutaneous metastasis poison sumac) 71. Tinea versicolor 5. Subacute eczematous inflammation 72. Tinea of the nails NEVI AND MALIGNANT MELANOMA 6. Chronic eczematous inflammation 73. Angular cheilitis 135. Nevi, melanocytic nevi, moles 7. Lichen simplex chronicus 74. Cutaneous fungal infections (tinea) 136. Atypical mole syndrome (dysplastic nevus 8. Hand eczema 75. Tinea of the foot syndrome) 9. Asteatotic eczema 76. Tinea of the groin 137. Malignant melanoma, lentigo maligna 10. Chapped, fissured feet 77. Tinea of the body 138. Melanoma mimics 11. Allergic contact dermatitis 78. Tinea of the hand 139. Congenital melanocytic nevi 12. Irritant contact dermatitis 79. Tinea incognito 13. Fingertip eczema 80. Tinea of the scalp VASCULAR TUMORS AND MALFORMATIONS 14. Keratolysis exfoliativa 81. Tinea of the beard 140. Hemangiomas of infancy 15. Nummular eczema 141. Vascular malformations 16. Pompholyx EXANTHEMS AND DRUG REACTIONS 142. Cherry angioma 17. Prurigo nodularis 82. Non-specific viral rash 143. Angiokeratoma 18. Stasis dermatitis 83.
    [Show full text]
  • Clinicopathological Correlation of Acquired Hyperpigmentary Disorders
    Symposium Clinicopathological correlation of acquired Dermatopathology hyperpigmentary disorders Anisha B. Patel, Raj Kubba1, Asha Kubba1 Department of Dermatology, ABSTRACT Oregon Health Sciences University, Portland, Oregon, Acquired pigmentary disorders are group of heterogenous entities that share single, most USA, 1Delhi Dermatology Group, Delhi Dermpath significant, clinical feature, that is, dyspigmentation. Asians and Indians, in particular, are mostly Laboratory, New Delhi, India affected. Although the classic morphologies and common treatment options of these conditions have been reviewed in the global dermatology literature, the value of histpathological evaluation Address for correspondence: has not been thoroughly explored. The importance of accurate diagnosis is emphasized here as Dr. Asha Kubba, the underlying diseases have varying etiologies that need to be addressed in order to effectively 10, Aradhana Enclave, treat the dyspigmentation. In this review, we describe and discuss the utility of histology in the R.K. Puram, Sector‑13, diagnostic work of hyperpigmentary disorders, and how, in many cases, it can lead to targeted New Delhi ‑ 110 066, India. E‑mail: and more effective therapy. We focus on the most common acquired pigmentary disorders [email protected] seen in Indian patients as well as a few uncommon diseases with distinctive histological traits. Facial melanoses, including mimickers of melasma, are thoroughly explored. These diseases include lichen planus pigmentosus, discoid lupus erythematosus, drug‑induced melanoses, hyperpigmentation due to exogenous substances, acanthosis nigricans, and macular amyloidosis. Key words: Facial melanoses, histology of hyperpigmentary disorders and melasma, pigmentary disorders INTRODUCTION focus on the most common acquired hyperpigmentary disorders seen in Indian patients as well as a few Acquired pigmentary disorders are found all over the uncommon diseases with distinctive histological traits.
    [Show full text]
  • Q-Switched Laser-Induced Chrysiasis Treated with Long-Pulsed Laser
    THE CUTTING EDGE SECTION EDITOR: GEORGE J. HRUZA, MD; ASSISTANT SECTION EDITORS: DEE ANNA GLASER, MD; ELAINE SIEGFRIED, MD Q-Switched Laser-Induced Chrysiasis Treated With Long-Pulsed Laser Patricia Lee Yun, MD; Kenneth A. Arndt, MD; R. Rox Anderson, MD; Wellman Laboratories of Photomedicine, Massachusetts General Hospital, Boston (Drs Yun and Anderson), Skin Care Physicians of Chestnut Hill, Chestnut Hill, Mass (Dr Arndt) The Cutting Edge: Challenges in Medical and Surgical Therapeutics REPORT OF A CASE on her cheeks and forehead ranging from 2 to 6 mm (Figure 1). The lesions did not enhance on Wood’s light A 70-year-old woman presented for elective treatment of examination, suggesting dermal pigmentation. In some lentigines on her face. This was her first treatment with areas, portions of the original lentigo were still visible in any laser. She was treated with a Q-switched alexan- the center of the blue macule. There was no discolora- drite laser (755 nm, 50 nanoseconds, 3.5 J/cm2, 15 pulses tion of the sclera, nails, or hair. A subtle blue-gray hue of 4-mm spot diameter; Candela, Wayland, Mass), caus- in the patient’s general skin color was noted at the time ing what appeared to be usual purpura immediately fol- of reexamination. lowing laser exposure of 8 tan macules. Several weeks A punch biopsy specimen of a representative area dem- later, blue-black discoloration was present, and was at- onstrated numerous black particles within macrophages tributed to postinflammatory hyperpigmentation, but in the dermis. A diagnosis of Q-switched laser-induced failed to lighten over the next 4 months.
    [Show full text]
  • Diagnostic Pitfall of Localized Lentigo Accompanied by Post-Inflammatory
    Letter to the Editor Diagnostic pitfall of localized lentigo accompanied by post-inflammatory pigmentation on the palm with a several-month history Keisuke Imafuku, Hiroo Hata, Shinya Kitamura, Toshifumi Nomura, Hiroshi Shimizu Department of Dermatology, Hokkaido University Graduate School of MedicineNorth 15, West 7, Kita-ku, Sapporo 060- 8638, Japan Corresponding author: Dr. Hiroo Hata, MD, PhD, E-mail: [email protected] Sir, When dermatologists see acquired and well- circumscribed pigmented macules on the palm, dorsal hand or forearm of the elderly, they tend to consider blue nevus, hematoma, nevus cell nevus and malignant melanoma as differential diagnoses [1]. We a b herein described the very rare case of localized lentigo Figure 1: Clinical manifestations. a. The macule is brown to dark black, accompanied by post-inflammatory pigmentation well-demarcated, flat, round and 3 x 4 mm in size. b. Dermoscopy of the macule shows homogenous brownish pigmentation without the in a patient who has been treated for palmoplanter parallel ridge or furrow pattern that is commonly observed in acral pustulosis for a long time. This eruption mimicked lentiginous lesion some kinds of lentiginous lesion and it was difficult to diagnose clinically. A 59-year-old female was referred to our hospital with a pigmented macule on her left palm. She had been to the family doctor for treatment of palmoplanter pustulosis by topical steroid ointment application for several years. According to the a history-taking interview, she said that the lesion had b appeared 5 months before referral to our hospital as a tiny pigmented macule and had gradually enlarged during those 5 months (Fig.
    [Show full text]
  • Hydroxychloroquine-Associated Hyperpigmentation Mimicking Elder Abuse
    Dermatol Ther (Heidelb) (2013) 3:203–210 DOI 10.1007/s13555-013-0032-z CASE REPORT Hydroxychloroquine-Associated Hyperpigmentation Mimicking Elder Abuse Philip R. Cohen To view enhanced content go to www.dermtherapy-open.com Received: June 17, 2013 / Published online: August 14, 2013 Ó The Author(s) 2013. This article is published with open access at Springerlink.com ABSTRACT cleared of suspected elder abuse. A skin biopsy of the patient’s dyschromia confirmed the Background: Hydroxychloroquine may result diagnosis of hydroxychloroquine-associated in cutaneous dyschromia. Older individuals hyperpigmentation. who are the victims of elder abuse can present Conclusion: Hyperpigmentation of skin, with bruising and resolving ecchymoses. mucosa, and nails can be observed in patients Purpose: The features of hydroxychloroquine- treated with antimalarials, including associated hyperpigmentation are described, hydroxychloroquine. Elder abuse is a significant the mucosal and skin manifestations of elder and underreported problem in seniors. abuse are reviewed, and the mucocutaneous Cutaneous findings can aid in the discovery of mimickers of elder abuse are summarized. physical abuse, sexual abuse, and self-neglect in Case Report: An elderly woman being treated elderly individuals. However, medication- with hydroxychloroquine for systemic lupus associated effects, systemic conditions, and erythematosus developed drug-associated black accidental external injuries can mimic elder and blue pigmentation of her skin. The abuse. Therefore, a complete medical history dyschromia was misinterpreted by her and appropriate laboratory evaluation, including clinician as elder abuse and Adult Protective skin biopsy, should be conducted when the Services was notified. The family was eventually diagnosis of elder abuse is suspected. Keywords: Abuse; Dyschromia; Elderly; P.
    [Show full text]
  • Ocular Chrysiasis: a Teaching Case Report | 1
    Ocular Chrysiasis: a Teaching Case Report | 1 Abstract Ocular chrysiasis is a deposition of gold in ocular structures secondary to gold salt therapy, which is primarily used in infectious, rheumatoid and psoriatic arthritis. Gold therapy has become an extremely rare treatment due to the advent of rheumatologic medications with better safety profiles. However, any patient who has undergone gold therapy could potentially have ocular chrysiasis. Therefore, it must be included as a differential in the presence of corneal or lenticular changes in these patients. Additionally, it is important to include ocular chrysiasis as a differential in the presence of crystalline keratopathies. A detailed medical history and thorough ocular examination can assist clinicians in making a correct diagnosis. Key Words: gold salts, ocular chrysiasis, autoimmune disease, cornea Background The following case report is meant to be used as a guide in teaching optometry students and residents. It is relevant to all levels of training. Ocular chrysiasis is a deposition of gold in ocular structures following chrysotherapy, which is the medical use of gold salts. Chrysotherapy was primarily used to treat infectious, rheumatoid and psoriatic arthritis. This therapy has become an extremely rare treatment due to the advent of rheumatologic medications with better safety profiles. Any patient who has undergone gold therapy could potentially have ocular chrysiasis. Therefore, it must be included as a differential in the presence of corneal or lenticular changes in these patients. This case illustrates the importance of history-taking skills, examination and decision-making in effectively diagnosing this condition. Case Description A 54-year-old Caucasian female presented for an annual eye examination.
    [Show full text]
  • Metastasizing Melanoma Formation Caused by Expression of Activated N-Rasq61k on an Ink4a-Deficient Background
    Research Article Metastasizing Melanoma Formation Caused by Expression of Activated N-RasQ61K on an INK4a-Deficient Background Julien Ackermann,1 Manon Frutschi,1 Kostas Kaloulis,1 Thomas McKee,2 Andreas Trumpp,1 and Friedrich Beermann1 1ISREC, Swiss Institute for Experimental Cancer Research, National Center of Competence in Research Molecular Oncology, Epalinges, Switzerland and 2Institute of Pathology, University of Lausanne, Lausanne, Switzerland Abstract the most common factors predisposing to melanoma formation in humans is the INK4a/ARF locus (4), which is inactivated with high In human cutaneous malignant melanoma, a predominance of frequency in human melanoma. This locus encodes two distinct activated mutations in the N-ras gene has been documented. INK4a ARF ARF To obtain a mouse model most closely mimicking the human proteins by alternative exon usage, p16 and p14 (p19 in disease, a transgenic mouse line was generated by targeting mice), which function as tumor suppressor genes in the pRB and expression of dominant-active human N-ras (N-RasQ61K) to the p53 pathways, respectively (4, 5). Gene-targeted mice, where p16INK4a and p19ARF are deleted, develop a large variety of tumors melanocyte lineage by tyrosinase regulatory sequences INK4a Q61K but fail to develop melanoma (6). Mice deficient in p16 but (Tyr::N-Ras ). Transgenic mice show hyperpigmented skin ARF and develop cutaneous metastasizing melanoma. Consistent which retain one copy of p19 show carcinogen-induced with the tumor suppressor function of the INK4a locus that susceptibility to metastatic melanoma (7, 8). Transgenic mice that encodes p16INK4A and p19ARF, >90% of Tyr::N-RasQ61K INK4aÀ/À express a mutant form of H-ras specifically in melanocytes showed melanocytic hyperplasia with intense skin pigmentation (9), which transgenic mice develop melanoma at 6 months.
    [Show full text]
  • Hutchinson's Melanotic Freckle
    Hutchiso’s elaotic freckle Also known as Lentigo maligna What is lentigo maligna? Lentigo maligna is an early form of melanoma. In lentigo maligna the cancer cells are confined to the upper layer of the skin (epidermis). When the cancer cells spread deeper into the skin (to dermis) it is called lentigo maligna melanoma. Lentigo maligna occurs most commonly in sun damaged areas such as the face and neck in fair skinned people over the age of 60. The lesion grows slowly in size over a number of years. Melanoma is a potentially lethal disease and lentigo maligna should be diagnosed and excised as soon as possible. What causes lentigo maligna? The cause of lentigo maligna is sun exposure or solarium use. Factors that predispose a person to developing lentigo maligna or associated condition include: . chronic sun damaged/solar-induced skin damage . fair skin complexion . male gender . a personal history of non melanoma skin cancer and precancerous lesions . older individuals (those between 60 to 80 years are most commonly affected) What does lentigo maligna look like? Lentigo maligna commonly looks like a freckle, age spot, sun spot or brown patch that slowly changes shape and grows in size. The spot may be large in size, irregularly shaped with a smooth surface, and of multiple shades of brown and sometimes other colours. Thickening of part of the lesion, increasing number of colours, ulceration or bleeding can be markers that the lesion is changing into a lentigo maligna melanoma. How is lentigo maligna diagnosed? Lentigo maligna is diagnosed clinically by a dermatologist, sometimes with the help of a dermatoscope (a tool used to magnify and look closely at skin moles).
    [Show full text]
  • Pigmented Contact Dermatitis and Chemical Depigmentation
    18_319_334* 05.11.2005 10:30 Uhr Seite 319 Chapter 18 Pigmented Contact Dermatitis 18 and Chemical Depigmentation Hideo Nakayama Contents ca, often occurs without showing any positive mani- 18.1 Hyperpigmentation Associated festations of dermatitis such as marked erythema, with Contact Dermatitis . 319 vesiculation, swelling, papules, rough skin or scaling. 18.1.1 Classification . 319 Therefore, patients may complain only of a pigmen- 18.1.2 Pigmented Contact Dermatitis . 320 tary disorder, even though the disease is entirely the 18.1.2.1 History and Causative Agents . 320 result of allergic contact dermatitis. Hyperpigmenta- 18.1.2.2 Differential Diagnosis . 323 tion caused by incontinentia pigmenti histologica 18.1.2.3 Prevention and Treatment . 323 has often been called a lichenoid reaction, since the 18.1.3 Pigmented Cosmetic Dermatitis . 324 presence of basal liquefaction degeneration, the ac- 18.1.3.1 Signs . 324 cumulation of melanin pigment, and the mononucle- 18.1.3.2 Causative Allergens . 325 ar cell infiltrate in the upper dermis are very similar 18.1.3.3 Treatment . 326 to the histopathological manifestations of lichen pla- 18.1.4 Purpuric Dermatitis . 328 nus. However, compared with typical lichen planus, 18.1.5 “Dirty Neck” of Atopic Eczema . 329 hyperkeratosis is usually milder, hypergranulosis 18.2 Depigmentation from Contact and saw-tooth-shape acanthosis are lacking, hyaline with Chemicals . 330 bodies are hardly seen, and the band-like massive in- 18.2.1 Mechanism of Leukoderma filtration with lymphocytes and histiocytes is lack- due to Chemicals . 330 ing. 18.2.2 Contact Leukoderma Caused Mainly by Contact Sensitization .
    [Show full text]
  • Laser Treatment for Pigmentation
    Laser treatment for pigmentation Sunspots and freckles In lesions such as solar lentigines (sun induced age spots), lentigo simplex and ephelides (freckles) the pigment (melanin) is in the top layers of the skin. Many lasers that selectively target melanin or simply remove the top layers will lead to improvement. One to two treatments will be necessary. There are many non-laser treatment approaches to treat such spots. However, if laser therapy is chosen, there are many different types of laser that can be used including Q-switched lasers [Q switched (QS) alexandrite, QS ruby (694nm)], long-pulsed, fractionated thulium (1927nm) and ablative lasers. IPL (filter 500-600nm) can also be very effective. However, it is common to see the pigmentation return over time. Treatments need to be avoided if the skin is tanned because this greatly increases the risk of complications. Seborrhoeic warts and dermatosis papulosa nigra Some conditions that present as dark spots are in fact wart-like and sit on the surface of the skin such as seborhoeic keratoses and dermatosis papulosa nigra and epidermal naevi. These conditions require physical removal. This is most commonly treated with a curette if thick or with fine wire diathermy particularly for the dermatosis papulosa nigra. Ablative lasers may also be used including CO2 in combination with a curette or an erbium YAG laser which reliably gives the best results. These lesions have a tendency to return over a number of years and maintenance treatments may be needed. Pigmented birth marks – Becker’s naevus Current lasers are unable to remove pigmented birthmarks without scarring.
    [Show full text]
  • Dermatopathology
    Dermatopathology Clay Cockerell • Martin C. Mihm Jr. • Brian J. Hall Cary Chisholm • Chad Jessup • Margaret Merola With contributions from: Jerad M. Gardner • Talley Whang Dermatopathology Clinicopathological Correlations Clay Cockerell Cary Chisholm Department of Dermatology Department of Pathology and Dermatopathology University of Texas Southwestern Medical Center Central Texas Pathology Laboratory Dallas , TX Waco , TX USA USA Martin C. Mihm Jr. Chad Jessup Department of Dermatology Department of Dermatology Brigham and Women’s Hospital Tufts Medical Center Boston , MA Boston , MA USA USA Brian J. Hall Margaret Merola Department of Dermatology Department of Pathology University of Texas Southwestern Medical Center Brigham and Women’s Hospital Dallas , TX Boston , MA USA USA With contributions from: Jerad M. Gardner Talley Whang Department of Pathology and Dermatology Harvard Vanguard Medical Associates University of Arkansas for Medical Sciences Boston, MA Little Rock, AR USA USA ISBN 978-1-4471-5447-1 ISBN 978-1-4471-5448-8 (eBook) DOI 10.1007/978-1-4471-5448-8 Springer London Heidelberg New York Dordrecht Library of Congress Control Number: 2013956345 © Springer-Verlag London 2014 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. Exempted from this legal reservation are brief excerpts in connection with reviews or scholarly analysis or material supplied specifi cally for the purpose of being entered and executed on a computer system, for exclusive use by the purchaser of the work.
    [Show full text]
  • Tattooed Skin and Health
    Current Problems in Dermatology Editors: P. Itin, G.B.E. Jemec Vol. 48 Tattooed Skin and Health Editors J. Serup N. Kluger W. Bäumler Tattooed Skin and Health Current Problems in Dermatology Vol. 48 Series Editors Peter Itin Basel Gregor B.E. Jemec Roskilde Tattooed Skin and Health Volume Editors Jørgen Serup Copenhagen Nicolas Kluger Helsinki Wolfgang Bäumler Regensburg 110 figures, 85 in color, and 25 tables, 2015 Basel · Freiburg · Paris · London · New York · Chennai · New Delhi · Bangkok · Beijing · Shanghai · Tokyo · Kuala Lumpur · Singapore · Sydney Current Problems in Dermatology Prof. Jørgen Serup Dr. Nicolas Kluger Bispebjerg University Hospital Department of Skin and Allergic Diseases Department of Dermatology D Helsinki University Central Hospital Copenhagen (Denmark) Helsinki (Finland) Prof. Wolfgang Bäumler Department of Dermatology University of Regensburg Regensburg (Germany) Library of Congress Cataloging-in-Publication Data Tattooed skin and health / volume editors, Jørgen Serup, Nicolas Kluger, Wolfgang Bäumler. p. ; cm. -- (Current problems in dermatology, ISSN 1421-5721 ; vol. 48) Includes bibliographical references and indexes. ISBN 978-3-318-02776-1 (hard cover : alk. paper) -- ISBN 978-3-318-02777-8 (electronic version) I. Serup, Jørgen, editor. II. Kluger, Nicolas, editor. III. Bäumler, Wolfgang, 1959- , editor. IV. Series: Current problems in dermatology ; v. 48. 1421-5721 [DNLM: 1. Tattooing--adverse effects. 2. Coloring Agents. 3. Epidermis--pathology. 4. Tattooing--legislation & jurisprudence. 5. Tattooing--methods. W1 CU804L v.48 2015 / WR 140] GT2345 391.6’5--dc23 2015000919 Bibliographic Indices. This publication is listed in bibliographic services, including MEDLINE/Pubmed. Disclaimer. The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publisher and the editor(s).
    [Show full text]